Stay updated with breaking news from Everbridge Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moneycontrol had reported citing sources that three private equity funds- Chrys Capital, Capital Group and Everbridge Partners, were looking to pare stake in Mankind Pharma worth at least $592 million through block deals.
A daily round-up of the most interesting articles to help jump-start the day.
Kotak Mahindra Capital is one of the advisors to the deal, and the private equity investors are offering a discount of upto 7% from the current price. The floor price has been set at Rs 1,785.65 a share.
Australia-based Pacific Equity Partners has reportedly closed a A$400 million ($265 million) single-asset continuation fund.
Singapore's sovereign wealth fund, GIC, and NewQuest Capital Partners have backed a $267-million South Asia continuation fund by Everbridge Partners.